Cortellis Drug Discovery Intelligence

Drug discovery and preclinical intelligence integrating multi-source data to accelerate R&D and avoid late-stage failures.

Overview

Cortellis Drug Discovery Intelligence, developed by Clarivate, is a comprehensive drug intelligence platform designed to accelerate R&D by supporting preclinical development and helping researchers avoid costly late-stage failures. By integrating multi-source data into a single unified platform, it provides life sciences professionals with the insights needed to make informed decisions throughout the drug discovery and preclinical development process.

The platform is built for researchers, scientists, and R&D teams working across pharmaceutical and biotechnology organisations who require reliable, consolidated intelligence to streamline their discovery workflows and reduce the risk of attrition in later development stages.

Core Capabilities

Integration of multi-source drug discovery and preclinical data into one centralised platform
Acceleration of preclinical development through access to comprehensive drug intelligence
Support for early-stage R&D decision-making to reduce late-stage failures
Access to discovery and development intelligence spanning the full preclinical research lifecycle

Platform Focus Areas

Drug discovery intelligence to inform target identification and validation
Preclinical development data to support compound progression decisions
Research and development insights covering the discovery and development continuum
Consolidated data environment enabling efficient navigation of complex R&D landscapes

Cortellis Drug Discovery Intelligence is part of the broader Clarivate Cortellis suite of life sciences intelligence solutions, which also includes Cortellis CMC Intelligence and Cortellis Product Intelligence, allowing organisations to access complementary data sets across the drug development value chain.